Facebook tracking pixel
S10.AI
ICD-10-CM · O99.810GeneralSystemic

Abnormal Glucose in Pregnancy

Understanding Abnormal Glucose in Pregnancy, also known as Glucose Intolerance in Pregnancy or Hyperglycemia in Pregnancy, is crucial for proper healthcare documentation and medical coding. This page provides information on diagnosing and managing abnormal glucose levels during pregnancy, including relevant clinical terms and coding guidelines for accurate medical records. Learn about the importance of monitoring blood glucose in pregnancy and best practices for optimal maternal and fetal health.

Also known as
Glucose Intolerance in PregnancyHyperglycemia in Pregnancy
Definition

High blood sugar during pregnancy, affecting both mother and baby.

Clinical signs

Often asymptomatic. May include increased thirst, urination, fatigue.

Common settings

Prenatal checkups, routine blood tests, diabetes clinics.

Related Codes

ICD-10 Code Families

Complete code families applicable to O99.810

O24
Diabetes mellitus in pregnancy
O99.4
Other maternal diseases classifiable elsewhere
R73
Elevated blood glucose level
Code Comparison

When to use each related code

DescriptionWhen to use
High blood sugar during pregnancy.Use for all types of abnormal glucose during pregnancy. Includes GDM, gestational impaired glucose tolerance.
Diabetes diagnosed during pregnancy.Use for pre-existing diabetes mellitus diagnosed during pregnancy, including type 1 and type 2.
High blood sugar first found after delivery.Glucose intolerance or diabetes discovered postpartum. Not for abnormal glucose found during pregnancy.
Documentation

Best-practice checklist

  • Document gestational age at diagnosis of abnormal glucose.
  • Specify type of abnormal glucose: gestational diabetes, pre-existing diabetes, other.
  • Record fasting, 1-hour, 2-hour, and 3-hour glucose levels.
  • Document any treatment plan, including diet, exercise, or medication.
  • Note any complications related to abnormal glucose, e.g., macrosomia.
Coding & Audit Risks

Common pitfalls to avoid

Gestational Diabetes Miscoding

Confusing abnormal glucose with gestational diabetes (GDM) or other hyperglycemic conditions can lead to inaccurate coding (O24 vs. A1C elevation).

Unspecified Glucose Abnormality

Lack of specific documentation (e.g., timing, values) may result in coding unspecified glucose abnormality, impacting reimbursement and data quality.

Overlooked Pre-existing Diabetes

Attributing abnormal glucose solely to pregnancy without considering pre-existing diabetes (type 1, type 2) can lead to undercoding and missed risk adjustment.

Mitigation

Best-practice tips

  • 01Optimize GDM coding with ICD-10-CM O24 codes.
  • 02Improve clinical documentation for hyperglycemia in pregnancy with specific details.
  • 03Ensure timely glucose screening per ACOG guidelines for compliant prenatal care.
  • 04Monitor blood glucose levels regularly & document for accurate risk assessment.
  • 05Educate patients on gestational diabetes mellitus (GDM) management for optimal outcomes.
Clinical Decision Support

Step-by-step checklist

  1. 1

    Confirm gestational age via LMP and ultrasound (ICD-10 O24)

  2. 2

    Check fasting, 1-hr, and 2-hr glucose levels (CPT 82950, 82951)

  3. 3

    Document patient's A1C and risk factors (SNOMED CT 439723000)

  4. 4

    Review diet, exercise, and medications for glucose control

  5. 5

    Assess for signs/symptoms of hyperglycemia and fetal well-being

Documentation Template

Ready-to-paste narrative

Patient presents with abnormal glucose levels during pregnancy, consistent with a diagnosis of gestational diabetes mellitus (GDM).  Risk factors assessed included family history of diabetes, pre-pregnancy BMI, and prior history of gestational diabetes.  Initial screening revealed elevated glucose levels on a 1-hour glucose challenge test (GCT).  Subsequent diagnostic testing with a 3-hour oral glucose tolerance test (OGTT) confirmed the diagnosis, meeting Carpenter and Coustan criteria.  Patient education provided on gestational diabetes management, including dietary modifications, self-monitoring of blood glucose, and the importance of regular prenatal care.  Treatment plan initiated focusing on lifestyle interventions with medical nutrition therapy and moderate exercise.  Patient instructed on proper blood glucose monitoring techniques and target ranges.  Risks of uncontrolled gestational diabetes, including macrosomia, preeclampsia, and neonatal hypoglycemia, were discussed.  Follow-up appointments scheduled to monitor glucose control, fetal well-being, and assess the need for pharmacologic intervention such as insulin therapy if lifestyle modifications are insufficient.  Patient understands the diagnosis and the importance of adhering to the prescribed treatment plan.  ICD-10 code O24.411, Gestational diabetes mellitus, in pregnancy, complicating pregnancy, childbirth, and the puerperium, first trimester, will be used for billing purposes.
FAQs

Common questions and answers

What are the diagnostic criteria for gestational diabetes mellitus (GDM) compared to other forms of abnormal glucose in pregnancy, such as impaired glucose tolerance (IGT) or gestational impaired fasting glucose (GIFG)?+

Gestational diabetes mellitus (GDM) is diagnosed using the one-step or two-step approach based on the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria. This involves a 75g oral glucose tolerance test (OGTT) performed between 24-28 weeks of gestation. GDM is diagnosed if any of the following thresholds are met: fasting plasma glucose >= 92 mg/dL, 1-hour plasma glucose >= 180 mg/dL, or 2-hour plasma glucose >= 153 mg/dL. Impaired glucose tolerance (IGT) in pregnancy refers to glucose levels above normal but below the diagnostic threshold for GDM during the OGTT. Similarly, gestational impaired fasting glucose (GIFG) refers to elevated fasting glucose levels below the GDM threshold. Differentiating between these conditions is crucial for appropriate management and risk stratification. Explore how utilizing diagnostic criteria aids in accurately identifying and managing patients with different types of hyperglycemia in pregnancy.

How do I manage abnormal glucose in pregnancy, specifically focusing on lifestyle interventions and pharmacotherapy options for patients with GDM, IGT, or GIFG?+

Management of abnormal glucose in pregnancy, encompassing GDM, IGT, and GIFG, often starts with lifestyle interventions, including medical nutrition therapy (MNT) provided by a registered dietitian and a tailored exercise program focusing on moderate-intensity aerobic activity. MNT emphasizes controlled carbohydrate intake, balanced meals, and regular snacks to maintain stable glucose levels. If lifestyle interventions are insufficient to achieve glycemic control, pharmacotherapy may be necessary. Insulin is the preferred medication for GDM, but some clinicians consider metformin or glyburide as alternatives if appropriate based on patient-specific factors and shared decision-making. Consider implementing a stepped-care approach, beginning with lifestyle changes and escalating to pharmacotherapy if targets are not met. Learn more about tailoring management strategies to individual patient needs and the latest evidence-based recommendations for both lifestyle and pharmacological interventions.

What are the maternal and fetal complications associated with various forms of abnormal glucose tolerance during pregnancy, including GDM, IGT, and GIFG, and how can they be mitigated through appropriate management?+

Abnormal glucose tolerance during pregnancy, including GDM, IGT, and GIFG, is associated with several maternal and fetal complications. Maternal risks include preeclampsia, cesarean delivery, and increased risk of developing type 2 diabetes later in life. Fetal complications can include macrosomia, shoulder dystocia, neonatal hypoglycemia, and an increased risk of childhood obesity and type 2 diabetes. Effective management, incorporating lifestyle modifications, blood glucose monitoring, and pharmacotherapy when necessary, is essential to minimize these risks. Strict glycemic control is key to improving maternal and fetal outcomes. Learn more about the long-term implications of abnormal glucose tolerance in pregnancy and strategies to optimize both maternal and fetal health throughout the pregnancy and postpartum period.

Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.

Coding standard: ICD-10-CM, current FY guidelines.